Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
UT MD Anderson Cancer Center
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Neoadjuvant therapy
Drugall patients will start/continue neoadjuvant systemic therapy
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Lymphedema Life Impact Scale (LLIS) questionnaire
Time frame
Through study completion; an average of 1 year.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov